Brightseed Stock

Brightseed is a pioneer in biosciences and artificial intelligence that illuminates nature to restore human health.

Sign up today and learn more about Brightseed Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Brightseed Stock

Brightseed is a pioneer in biosciences and artificial intelligence that illuminates nature to restore human health. Through Forager® A.I. and clinical evaluation, Brightseed helps companies gain the deepest insight into bioactives and their innovation potential. Forager A.I. accelerates bioactive discovery and biological validation from years to months – and is rapidly revealing new connections between nature and humanity. Brightseed partners with companies across the consumer health continuum to provide novel insights and science-backed health solutions. Learn more about www.brightseedbio.com. About Bioactives Bioactives are small molecule compounds produced by plants, fungi, and microbes that grow in and adapt to environments that present a wide range of challenges to their survival. Bioactives also benefit the health of humans – they are the enlivening caffeine in tea, the powerful antioxidant lycopene in tomatoes, and they inform active ingredients in medicines like Taxol, Aspirin and Metformin, a first-line treatment for Type 2 diabetes, derived from the French lilac flower. Science has long known that bioactives are critical to human health, yet the vast majority remain unknown and uncharted. Brightseed’s A.I., Forager®, discovers bioactives in nature and maps them to human health outcomes at a rate and accuracy that was previously impossible.

Funding History

September 2018$6.0M
April 2019$18.0M
September 2020$27.0M
November 2021$200K
May 2022$68.0M

Management

Co-Founder and CEO

Jim Flatt

Co-Founder, CSO, and CTO

Lee Chae

Co-Founder and COO

Sofia Elizondo

Advisor

Indra Nooyi

Advisor

Dariush Mozaffarian

Board of Director

David Russell

Advisor

Bernhard Van Lengerich

Advisor

Walter Robb

Board of Director

Elaine Leavenworth

Investor

Rob Leclerc

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo